… (PE) due to the high mortality risk associated with standard … of systemic thrombolytic therapy
with intravenous tissue plasminogen activator (IV-tPA) improves the survival of patients with …

… patients with acute PE who were treated with thrombolysis. There were 3,107 (70.20%) of
the 4,426 who received systemic thrombolysis… outcomes between the 2 study cohorts (systemic …

… , treatment of massive PE involved the prompt restoration of pulmonary perfusion via systemic
thrombolysis, and surgical embolectomy in those whom systemic thrombolysis has failed …

… Methods and results … controlled studies comparing systemic thrombolytic therapy plus
anticoagulation with anticoagulation alone in patients with acute PE. Fifteen trials involving 2057 …

… This volume–outcome relationship may be explained by differential access to … PE therapies
such as systemic thrombolysis, catheter-based embolectomy, catheter-directed thrombolysis, …

… treatment weighting (IPTW) by propensity scores to compare the outcomes between the
thrombolysis … the propensity scores for patients receiving systemic thrombolysis within two days …

… or submassive PE often results in severe hypoxia, RV failure with subsequent hemodynamic
collapse. Recent studies suggested that systemic thrombolytic therapy is associated with a …

… In our cohort of critically ill mechanically ventilated COVID-19 patients with acute hypoxic
respiratory failure treated with tPA for a presumed PE, for worsening hypoxemia and, or …

… about advanced invasive therapies like catheter-directed or systemic thrombolytic therapies.
… , may allow PERTs to better apply optimal therapies in a timely fashion for patients with PE. …

… we see these patients in the condition in which they are still clinically stable but have a
contraindication to heparin or systemic thrombolysis, then we undergo regional thrombolysis with …